Harnessing localised delivery of gut-selective therapy for ulcerative colitis

Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1031-1032. doi: 10.1016/S2468-1253(20)30292-2. Epub 2020 Oct 5.

Authors

Christopher Ma¹, Remo Panaccione²

Affiliations

¹ Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB T2N 4Z6, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada. Electronic address: christopher.ma@ucalgary.ca.
² Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB T2N 4Z6, Canada.

PMID: 33031759
DOI: 10.1016/S2468-1253(20)30292-2

No abstract available

Publication types

Comment

MeSH terms

Colitis, Ulcerative* / drug therapy
Double-Blind Method
Gastrointestinal Microbiome*
Humans
Probiotics*